|
| Andreou et al. [15] |
| Overall survival |
|
| Variable (bivariate analysis) | value |
| Sex | |
| Age (higher) | |
| Extremity versus axial + pelvis | |
| Tumor volume (0–100 cc vs. >100 cc) | |
| Grade tumor | |
| Local recurrences | |
| Distant metastasis | |
| Surgical margins | |
| Type of surgery | |
| Low grade: ablative versus limb-sparing | |
| High grade: ablative versus limb-sparing | |
| Pathologic fracture | |
| ACJCC | |
| Multi disc. versus support. care | |
| Variable (multivariate analysis) | |
| High grade: RR = 5 | |
|
Axial + pelvis: RR = 2 | |
|
| Staals et al. [25] |
| Disease-free survival |
|
| Variable (bivariate analysis) | value |
| Gender | NS |
| Age | NS |
| Duration of symptoms | NS |
| Lesion size | NS |
| Anatomic location | NS |
| Stage 3 versus Stage 2a | |
| Stage 3 versus Stage 2b | |
| Stage 2a versus Stage 2b | |
| Histologic subtype, MFH versus OS | |
| Histologic subtype, MFH versus fibr. sarc. | |
| Histologic subtype, OS versus fibr. sarc. | |
| Grade 3DD versus grade 4DD | |
| Percentage of DD component | |
| Percentage of DD component, >50% versus <50% | |
| Limb-sparing versus resection | |
| Surgery versus surgery + chemotherapy | |
| Variable (multivariate analysis, overall survival) | |
| Percentage of DD component | |
|
| Angelini et al. [16] |
| Overall survival |
|
| Variable (bivariate analysis) | value |
| G1: wide versus intralesional | |
| G1: extremity versus trunk | |
| G2: wide versus intralesional | |
| G2: extremity versus trunk | |
| G2: resect. versus amputation | |
| G3: extremity versus trunk | |
| G3: resect. versus amputation | |
| Variable (multivariate analysis) | |
| G3: resect. versus amputation | |
| G3: extr. versus trunk | |
|
| van Maldegem et al. [26] |
| Overall survival from the day of unresectability |
|
| Variable (bivariate analysis) | value |
| Only local unresectable disease versus local unresectable disease + metastasis | |
| Age (<40 years) | |
| Grade II tumors | |
| Sex | NS |
| Site | NS |
| Resectable versus nonresectable disease at primary diagnosis | NS |
| Systemic treatment | |
|
